(Q62811277)
Statements
A Phase 1a/1b Randomized Double-blind Placebo-controlled Single and Multiple Ascending Dose Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis (English)
0 references
24 April 2018
0 references
30 June 2019
0 references
96
0 references
18 year
0 references
60 year
0 references